Comparative GEANT4-based Monte Carlo dosimetry of I-125 and Pd-103 in soft tissue, blood, and adipose tissue
Pages 1-10
https://doi.org/10.22034/rpe.2025.550493.1303
Parvin Ahmadi, Reyhaneh Gili
Abstract This study presents a GEANT4-based Monte Carlo dosimetry comparison of clinically realistic I-125 (Amersham OncoSeed 6702) and Pd-103 (BEBIG IsoSeed) brachytherapy sources in adipose tissue, soft tissue, and blood. The simulation model was rigorously validated against AAPM TG-43 consensus data, showing excellent agreement in dose rate constants and radial dose functions. The model was thoroughly tested and validated to ensure its robustness and accuracy. Results demonstrated that tissue composition significantly alters dose distributions compared to water. Adipose tissue permitted the deepest penetration, while blood showed the strongest attenuation. The results indicated that I-125, align with its lower average energy, produced a broader dose distribution than Pd-103. Conversely, 103Pd exhibited a steeper dose gradient, confining energy closer to the source. These findings underscore the critical importance of incorporating both tissue-specific composition and the full photon energy spectrum into brachytherapy treatment planning to optimize dose delivery for personalized patient care ultimately optimizing clinical outcomes.
















